Watkins, D. A., Yamey, G., Schäferhoff, M., Adeyi, O., Alleyne, G., Alwan, A., … Summers, L. H. (2018). Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health. Lancet (London, England), 392(10156), 1434–1460. https://doi.org/10.1016/s0140-6736(18)32389-4

Watkins, David A., Gavin Yamey, Marco Schäferhoff, Olusoji Adeyi, George Alleyne, Ala Alwan, Seth Berkley, et al. “Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health.” Lancet (London, England) 392, no. 10156 (October 2018): 1434–60. https://doi.org/10.1016/s0140-6736(18)32389-4.

Watkins DA, Yamey G, Schäferhoff M, Adeyi O, Alleyne G, Alwan A, et al. Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health. Lancet (London, England). 2018 Oct;392(10156):1434–60.

Watkins, David A., et al. “Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health.” Lancet (London, England), vol. 392, no. 10156, Oct. 2018, pp. 1434–60. Epmc, doi:10.1016/s0140-6736(18)32389-4.

Watkins DA, Yamey G, Schäferhoff M, Adeyi O, Alleyne G, Alwan A, Berkley S, Feachem R, Frenk J, Ghosh G, Goldie SJ, Guo Y, Gupta S, Knaul F, Kruk M, Nugent R, Ogbuoji O, Qi J, Reddy S, Saxenian H, Soucat A, Jamison DT, Summers LH. Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health. Lancet (London, England). 2018 Oct;392(10156):1434–1460.